Clinical Drug Investigation

, Volume 31, Issue 5, pp 351–355 | Cite as

Safe Administration of Celecoxib to a Patient with Repeated Episodes of Nephrotic Syndrome Induced by NSAIDs

  • Karlo Mihovilovic
  • Danica Ljubanovic
  • Mladen KnotekEmail author
Case Report


Nephrotic syndrome, with or without concomitant tubulointerstitial nephritis, is a rare renal adverse effect of NSAIDs. In the present report we describe a case of a 60-year-old Caucasian man who was admitted because of nephrotic syndrome following several days of use of meloxicam for hip osteoarthritis. Renal histopathology revealed minimal change disease, one of the commonest causes of nephrotic syndrome. The patient’s condition resolved rapidly upon discontinuation of meloxicam. Because he had already experienced two episodes of nephrotic syndrome after administration of diclofenac several years previously, it was concluded that the patient had renal hypersensitivity to both diclofenac and meloxicam. While waiting for the hip arthroplasty, he was prescribed celecoxib for pain control. After 1 month of regular celecoxib use the patient remained in remission with respect to nephrotic syndrome and had normal renal function. We conclude that challenge with a structurally distinct NSAID (such as celecoxib in this case) may be an option, under close surveillance, in a patient with a history of nephrotic syndrome associated with use of an NSAID when continued treatment with an NSAID is indicated.


Atorvastatin Nephrotic Syndrome Celecoxib Losartan Rofecoxib 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No external sources of funding were used to prepare this report. The authors have no conflicts of interests relevant to this work. All authors significantly contributed to the work and met the criteria for authorship.


  1. 1.
    Hamza M, Dionne RA. Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition. Curr Mol Pharmacol 2009; 2(1): 1–14PubMedGoogle Scholar
  2. 2.
    Choudhury D, Ahmed Z. Drug-associated renal dysfunction and injury. Nat Clin Pract Nephrol 2006; 2(2): 80–91PubMedCrossRefGoogle Scholar
  3. 3.
    Warren GV, Korbet SM, Schwartz MM, et al. Minimal change glomerulopathy associated with nonsteroidal anti-inflammatory drugs. Am J Kidney Dis 1989; 13(2): 127–30PubMedGoogle Scholar
  4. 4.
    Bennett WM, Henrich WL, Stoff JS. The renal effects of nonsteroidal anti-inflammatory drugs: summary and recommendations. Am J Kidney Dis 1996; 28(1 Suppl. 1): S56–62PubMedCrossRefGoogle Scholar
  5. 5.
    Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med 1999; 106(5B): 13S–24SPubMedCrossRefGoogle Scholar
  6. 6.
    Almansori M, Kovithavongs T, Qarni MU. Cyclooxygenase-2 inhibitor-associated minimal-change disease. Clin Nephrol 2005; 63(5): 381–4PubMedGoogle Scholar
  7. 7.
    Alper Jr AB, Meleg-Smith S, Krane NK. Nephrotic syndrome and interstitial nephritis associated with celecoxib. Am J Kidney Dis 2002; 40(5): 1086–90PubMedCrossRefGoogle Scholar
  8. 8.
    Brewster UC, Perazella MA. Acute tubulointerstitial nephritis associated with celecoxib. Nephrol Dial Transplant 2004; 19(4): 1017–8PubMedCrossRefGoogle Scholar
  9. 9.
    Demke D, Zhao S, Arellano FM. Interstitial nephritis associated with celecoxib. Lancet 2001; 358(9294): 1726–7PubMedCrossRefGoogle Scholar
  10. 10.
    Esteve JB, Launay-Vacher V, Brocheriou I, et al. COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature. Clin Nephrol 2005; 63(5): 385–9PubMedGoogle Scholar
  11. 11.
    Henao J, Hisamuddin I, Nzerue CM, et al. Celecoxibinduced acute interstitial nephritis. Am J Kidney Dis 2002; 39(6): 1313–7PubMedCrossRefGoogle Scholar
  12. 12.
    Beun GD, Leunissen KM, Van Breda V, et al. Isolated minimal change nephropathy associated with diclofenac. Br Med J (Clin Res Ed) 1987; 295(6591): 182–3CrossRefGoogle Scholar
  13. 13.
    Ravnskov U. Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs: evidence of a common mechanism. Br J Clin Pharmacol 1999; 47(2): 203–10PubMedCrossRefGoogle Scholar
  14. 14.
    Perazella MA, Markowitz GS. Drug-induced acute interstitial nephritis. Nat Rev Nephrol 2010; 6(8): 461–70PubMedCrossRefGoogle Scholar
  15. 15.
    Mathieson PW. Minimal change nephropathy and focal segmental glomerulosclerosis. Semin Immunopathol 2007; 29(4): 415–26PubMedCrossRefGoogle Scholar
  16. 16.
    Cornejo-Garcia JA, Blanca-Lopez N, Dona I, et al. Hypersensitivity reactions to non-steroidal anti-inflammatory drugs. Curr Drug Metab 2009; 10(9): 971–80PubMedCrossRefGoogle Scholar
  17. 17.
    Rocha JL, Fernandez-Alonso J. Acute tubulointerstitial nephritis associated with the selective COX-2 enzyme inhibitor, rofecoxib. Lancet 2001; 357(9272): 1946–7PubMedCrossRefGoogle Scholar
  18. 18.
    Alim N, Peterson L, Zimmerman SW, et al. Rofecoxibinduced acute interstitial nephritis. Am J Kidney Dis 2003; 41(3): 720–1PubMedCrossRefGoogle Scholar
  19. 19.
    Quiralte J, Blanco C, Delgado J, et al. Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions. J Investig Allergol Clin Immunol 2007; 17(3): 182–8PubMedGoogle Scholar
  20. 20.
    Sanchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A. Tolerance of nonsteroidal anti-inflammatory drug-sensitive patients to the highly specific cyclooxygenase 2 inhibitors rofecoxib and valdecoxib. Ann Allergy Asthma Immunol 2005; 94(1): 34–8PubMedCrossRefGoogle Scholar
  21. 21.
    Senna G, Bilo MB, Antonicelli L, et al. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Eur Ann Allergy Clin Immunol 2004; 36(6): 215–8PubMedGoogle Scholar
  22. 22.
    Viola M, Quaratino D, Gaeta F, et al. Cross-reactive reactions to nonsteroidal anti-inflammatory drugs. Curr Pharm Des 2008; 14(27): 2826–32PubMedCrossRefGoogle Scholar
  23. 23.
    Weberschock TB, Muller SM, Boehncke S, et al. Tolerance to coxibs in patients with intolerance to non-steroidal antiinflammatory drugs (NSAIDs): a systematic structured review of the literature. Arch Dermatol Res 2007; 299(4): 169–75PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  • Karlo Mihovilovic
    • 1
  • Danica Ljubanovic
    • 2
  • Mladen Knotek
    • 1
    Email author
  1. 1.Renal Division, Department of MedicineUniversity of Zagreb Medical School, Clinical Hospital MerkurZagrebCroatia
  2. 2.Department of PathologyUniversity of Zagreb Medical School and Clinical Hospital DubravaZagrebCroatia

Personalised recommendations